Powder: -20°C for 3 years | In solvent: -80°C for 2 years
NNC45-0781 is a tissue-selective partial-agonist of estrogen.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 1,070.00
$ 856.00
|
|
50 mg | 6-8 weeks | $ 2,180.00
$ 1,744.00
|
|
100 mg | 6-8 weeks | $ 2,800.00
$ 2,240.00
|
Description | NNC45-0781 is a tissue-selective partial-agonist of estrogen. |
In vivo | NNC 45-0781 is a very promising candidate for the prevention of post-menopausal osteoporosis, and the treatment of other health issues related to the loss of endogenous estrogen production. |
Molecular Weight | 415.52 |
Formula | C27H29NO3 |
CAS No. | 207277-66-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NNC45-0781 207277-66-5 Others NNC45 0781 NNC-45-0781 NNC450781 inhibitor inhibit